ScholarMate
English简体中文繁體中文
客服热线:400-1616-289
登录注册
期刊论文

Design, Synthesis and Bioactivity Evaluation of Novel Chalcone Derivatives Possessing Tryptophan Moiety with Dual Activities of Anti-Cancer and Partially Restoring the Proliferation of Normal Kidney Cells Pre-Treated with Cisplatin

He, Meng; Yu, Mingjun; Li, Chao; Meng, Xiaoming; Su, Jiamin; Zhu, Yuting; Yao, Risheng*安徽医科大学
Anti-Cancer Agents in Medicinal Chemistry2022DOI: 10.2174/1871520621666211021134626
1被引9阅读
引用收藏
分享

摘要

Background: Chalcone is a broad-spectrum natural product with anti-cancer and anti-inflammatory activities. However, low potency, low selectivity, and serious side effects limit its druggability. L-Tryptophan is an essential precursor molecule of an anti-cancer active substance. Also, the indole moiety inhibits the proliferation of tumor cells by binding to colchicine sites. A decrease in kidney cell activity caused by kidney inflammation is the primary side effect of cancer therapy. Objective: The purpose of this work was to design, synthesize, and perform bioactivity evaluation of novel chalcone derivatives possessing tryptophan moiety with dual activities of anti-cancer and partially restoring the proliferation of normal kidney cells pre-treated with cisplatin. Methods: A series of novel chalcone derivatives possessing tryptophan moiety (5a-5g, 6a-6o) were designed, synthesized, and evaluated for anti-cancer activity against four cancer cell lines (gastric (HGC-27), colon (HCT-116), prostate (PC-3), and lung (A549)), and a human normal cell line (gastric mucosal epithelial (GES-1)). The activity of restoring the proliferation of normal kidney cells pre-treated with cisplatin was evaluated by MTT assay. Cell cycle, apoptosis, and apoptosis proteins (Bax and Bcl-2) were used to evaluate the anti-cancer mechanism of the most potent compound. Moreover, a docking study was performed to explain the high anti-cancer activity of 6n. The expressions of TNF-alpha, IL-6, and MCP-1 were detected by ELISA. Results: Most of the compounds exhibited high anti-cancer activity against the HGC-27 cell line and exhibited low toxicity against the normal cell line. Based on three rounds of a structure optimization, 6n was discovered as the most potent compound against HGC-27 cells with an IC50 value of 2.02 mu M and an SI value of 28.47. Further studies demonstrated that 6n could induce cell cycle arrest at the G2/M phase and the apoptosis of the HGC-27 cell line by reducing the expression of Bcl-2 and improving the expression level of Bax. Molecular docking result displayed 6n bound to the colchicine site. At the same time, 6n also exhibited moderate activity of restoring the proliferation of normal kidney cells pre-treated with cisplatin by reducing the expression of inflammatory substances. Conclusion: Our findings collectively suggested that 6n should be further studied as a potential anti-cancer agent that could partially restore the proliferation of normal kidney cells pre-treated with cisplatin in gastric cancer patients by an anti-inflammatory pathway.

学科与关键词

关键词
ChalconesL-tryptophananti-cancercolchicinenephrotoxicityHGC-27 cellsHK-2 cells
相关
加载中…
  • Design and Synthesis of Novel Chalcone Derivatives: Anti-Breast Cancer Activity Evaluation and Docking Study
    Lai, Weihong; Chen, Jiaxin; Gao, Xinjiao; Jin, Xiaobao; Chen, Gong*; Ye, Lianbao*INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES, 2023, 24(21): 15549.被引 1
  • Design, Synthesis, anticancer evaluation and in silico studies of 2,4,6-trimethoxychalcone derivatives
    Li, Tong; Li, Weiwei; Yang, Xianjing; Chen, Gong; Jin, Xiaobao; Chen, Weiqiang; Ye, Lianbao*SAUDI PHARMACEUTICAL JOURNAL, 2023, 31(1): 65-84.被引 5
  • Structure modification and biological evaluation of indole-chalcone derivatives as anti-tumor agents through dual targeting tubulin and TrxR
    Yan, Jun; Xu, Yuzhu; Jin, Xing; Zhang, Qiaoxuan; Ouyang, Feng; Han, Liqiao; Zhan, Min; Li, Xingshu; Liang, Baoxia*; Huang, Xianzhang*European Journal of Medicinal Chemistry, 2022, 227: 113897.被引 13
查看全部 →

发表信息

论文状态
公开发表
期刊
Anti-Cancer Agents in Medicinal Chemistry
发表日期
2022
卷期
第 22 卷, 第 10 期
页码
1945-1961
DOI
10.2174/1871520621666211021134626
语言
ENGLISH
期刊等级
4区
成果收录
SCIE
资助标注
National Natural Science Foundation of China [0601058205]

作者

  • H

    He, Meng (第一作者)

  • Y

    Yu, Mingjun

查看全部 7 位作者收起作者
  • L

    Li, Chao

    anhui med univ

  • M

    Meng, Xiaoming

    anhui med univ

  • S

    Su, Jiamin

  • Z

    Zhu, Yuting

  • Y

    Yao, Risheng (通讯)

登录解锁更多功能

  • 收藏这篇,随时在“我的 · 收藏”找回
  • 认领你的成果,生成推广素材
  • 关注作者获取最新成果
  • 加入项目组、协同写作
注册 / 登录

产品服务

  • 科研之友
  • 创新城
  • 科创云

服务支持

  • 帮助中心
  • 隐私政策
  • 服务条款

联系方式

在线客服:【】
客服热线:400-1616-289
电子邮箱:support@scholarmate.com

关注或下载科研之友

微信二维码
微信公众号
客户端下载二维码
下载客户端
科研成果科研人员科研机构科研动态爱瑞思软件

©2026 深圳市科研之友网络服务有限公司

公安备案图标粤公网安备 44030502000213
粤ICP备 16046710 号粤B2-20110417